propafenone has been researched along with ibutilide in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 17 (85.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chang, MS; Chen, SA; Chen, YJ; Feng, AN; Tai, CT; Yu, WC | 1 |
| Accardi, R; Cammilli, L; Catanzariti, D; Cozzi, F; Spagnolli, W; Vergara, G | 1 |
| Blitzer, M; Reiffel, JA | 1 |
| Abiose, A; Abordo, M; Berns, E; Dalamagas, H; Jaagosild, P; Lippman, N; Madhusoodanan, KP; Silverman, D; Soucier, R; Therrien, M | 1 |
| Kao, W; Kowey, PR; Winkel, E; Yan, GX | 1 |
| Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ | 1 |
| Chiladakis, JA; Kalogeropoulos, A; Manolis, AS; Patsouras, N | 1 |
| Bonso, A; Glatter, KA; Hongo, RH; Raviele, A; Rossillo, A; Scheinman, MM; Themistoclakis, S; Yang, Y | 1 |
| Guo, JH; Sun, JL; Zhang, HC; Zhang, N; Zhang, P | 1 |
| Fang, Q; Ge, JB; Guo, JH; Guo, JX; Han, SM; Sun, YM; Wan, Z; Zhang, HC; Zheng, YA; Zhu, WQ | 1 |
| Lynch, JJ; Regan, CP; Stump, GL; Wallace, AA | 1 |
| Draganigos, A; Goudevenos, JA; Katsouras, CS; Kolettis, TM; Kolios, P; Korantzopoulos, P; Leontaridis, I; Naka, KK; Papathanasiou, A | 1 |
| Fragakis, N; Katsaris, G; Kozirakis, M; Maligkos, G; Papadopoulos, N; Papanastasiou, S; Tsaritsaniotis, E | 1 |
| Scharf, C | 1 |
| Guo, JH; Li, XB; Xn, Y; Zhang, HCh; Zhang, N; Zhang, P | 1 |
| Ma, C; Xiang, M; Yang, Y; Yu, Z; Zhang, S | 1 |
3 review(s) available for propafenone and ibutilide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
8 trial(s) available for propafenone and ibutilide
| Article | Year |
|---|---|
Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared to rate control alone (the PIPAF study).
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Sulfonamides | 2003 |
Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome | 2004 |
Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Italy; Male; Middle Aged; Propafenone; Prospective Studies; San Francisco; Sulfonamides; Treatment Outcome | 2004 |
Clinical comparison of ibutilide and propafenone for converting atrial flutter.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Time Factors; Treatment Outcome | 2005 |
[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Single-Blind Method; Sulfonamides; Treatment Outcome | 2005 |
Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Propafenone; Sulfonamides; Treatment Outcome | 2006 |
Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Sulfonamides; Treatment Outcome | 2005 |
[Efficacy and safety of ibutilide for conversion of atrial fibrillation/flutter].
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Female; Humans; Male; Middle Aged; Propafenone; Sulfonamides; Treatment Outcome; Young Adult | 2013 |
9 other study(ies) available for propafenone and ibutilide
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Function; Cardiac Catheterization; Electrophysiology; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Sulfonamides | 1998 |
Pharmacological atrial defibrillation via temporarily occluded coronary sinus: first clinical experience and implications for an implantable device.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Infusion Pumps, Implantable; Male; Middle Aged; Propafenone; Sulfonamides | 2000 |
The actions of ibutilide and class Ic drugs on the slow sodium channel: new insights regarding individual pharmacologic effects elucidated through combination therapies.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Sodium Channels; Sulfonamides | 2000 |
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function | 2004 |
In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Atrial Function; Dogs; Electrocardiography; Electrophysiology; Female; Kv1.5 Potassium Channel; Male; Phosphines; Potassium Channel Blockers; Propafenone; Sulfonamides | 2005 |
Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome | 2005 |